D-mannose is a simple sugar (monosaccharide) that prevents urinary tract infections (UTIs) by a brilliantly simple mechanism: E. coli bacteria (causing 80-90% of UTIs) have FimH adhesins that bind mannose on bladder cells. Supplemental D-mannose floods the urinary tract with free mannose, which E. coli preferentially bind to INSTEAD of bladder cells — and then get flushed out during urination. A 2014 RCT found D-mannose was as effective as the antibiotic nitrofurantoin for UTI prevention (14.6% vs 20.4% recurrence), with far fewer side effects. This is one of the few supplements with a clear, validated molecular mechanism AND clinical confirmation.
E. coli uses FimH adhesins on type 1 pili (hair-like projections) to bind mannose residues on the surface of bladder epithelial cells — this is the first step in UTI colonization. D-mannose, when taken orally, is absorbed in the small intestine and excreted unchanged in urine within 30-60 minutes. In the urinary tract, free D-mannose molecules vastly outnumber the mannose residues on bladder cells. E. coli preferentially bind to the free D-mannose (decoy effect), preventing attachment to the bladder wall. With each urination, the bacteria (now bound to free mannose, not bladder cells) are flushed out. This is competitive inhibition of bacterial adhesion — not antibiotic, not antiseptic, just molecular trickery.
No critical interactions identified.
Reviewed by the Scan Dose Research Team and Clinical Advisory Board | Last updated:
Not medical advice. Based on published clinical research and systematic reviews.